Program Agenda

Day 1 - March 9, 2022

8:00-9:00 PM ET (CME Session):

  • Novel Strategies in Cardioprevention: Dual Pathway Inhibition
    Deepak L. Bhatt, MD, MPH

  • Update on Heart Failure with Reduced Ejection Fraction
    Javed Butler, MD, MPH, MBA

  • Resistant Hypertension
    George Bakris, MD

  • Beyond Glycemia: How to Best Prescribe Current Antihyperglycemic Agents
    Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

  • Health Care Maintenance in IBD for Primary Care
    Stephen B. Hanauer, MD

  • Cutaneous Manifestations of Systemic Disease
    April Armstrong, MD, MPH

  • Panel Discussion / Q and A
    Deepak L. Bhatt, MD, MPH and Panel

9:00 PM to 9:30 PM ET Expert Therapeutic Update Session (Non-CME)

Day 2 - March 10, 2022:

8:00-9:00 PM ET (CME Session):

  • Biosimilars: What a Primary Care should know
    Stephen B. Hanauer, MD

  • Update on Heart Failure with Preserved Ejection Fraction
    Javed Butler, MD, MPH, MBA

  • New Drugs for Chronic Kidney Disease
    George Bakris, MD

  • Lipid Modifying Drugs to Reduce Cardiovascular Risk
    Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

  • New Medications Used by Dermatologists: Key Effects and Side Effects Every Physician Should Know About
    April Armstrong, MD, MPH

  • Panel Discussion / Q and A
    Deepak L. Bhatt, MD, MPH and Panel

9:00 PM to 9:30 PM ET Expert Therapeutic Update Session (Non-CME)

CME INFORMATION

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Institute for Continuing Healthcare Education (Institute) and 360 Medical Education. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Institute designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™

Learning Objectives

After participating in this activity, participants will be better able to:

  • Describe the latest advances in heart failure, resistant hypertension, chronic kidney disease, dyslipidemia, diabetes, and inflammatory bowel disease.

  • Evaluate data from recent and ongoing trials in these areas.

  • Discuss the impact on clinical practice of all the new data.

Speaker Disclosures

Faculty disclosures and conflict of interest statements can be found in the Resource Center on the PCP360 Virtual Conference Platform.

How to Claim CME Credit

An online CME Evaluation form is available in the virtual platform, after completing the online evaluation, you will automatically be able to download a copy of your certificate. A copy will also be emailed to you.